We rank among the leading advisers and providers of legal expertise in Scandinavia and consist of a young and ambitious team with a unique understanding of our clients’ businesses with a particular focus on the process from the development to the final product.
We offer specialised legal know-how in relation to:
- Pharmaceutical products
- Medical devices
We assist Life Sciences and HealthTech companies with specialised corporate services, including:
- Counselling on clinical trials
- Protection of intellectual property rights
We are also significantly experienced in ligitation in:
- Conclusion of contracts
- Intellectual property issues
- Product development
- Legal actions
- Patent litigation
- Competition matters
- Consultation responses
- Angel and private equity fund investments
Our team of lawyers possesses a long-standing, practical experience in this line of business gained through employments with recognized Life Sciences and HealthTech companies and relevant authorities.
The still growing team consists of experienced corporate lawyers, patent lawyers and other intellectual property lawyers, experienced litigation lawyers, and lawyers with experience within regulatory compliance and risk assessment.
“Strong practice advising on all areas of IP law with a particular focus on the life sciences sector. Assists with contracts as well as contentious cases. Offers cross-border capabilities and has offices in the Baltic countries. Clients are pleased with the team’s commerciality and commitment, saying: “Responses are quick and the team is very dedicated.” Another client adds: “They are effective, proactive and reasonable in their approach.””
“‘Extremely flexible’, NJORD Law Firm has experience of acting for clients in the life sciences, retail and technology sectors. René Lykke Wethelund has been representing V2Tobacco in a number of trade mark disputes with VMR in Denmark, Sweden and the US regarding e-cigarettes. The team is jointly led by Jeppe Brogaard Clausen and Thomas Ryhl. Frank Jørgensen is now partner.”